1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MAZE THERAPEUTICS INC.
Maze Therapeutics Inc. XNAS: MAZE
Download real time
32.53 0.69 (2.17%)
384.08% Gain from 52W Low
912.7K
XNAS Volume
High volume today

XNAS 14 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Maze Therapeutics Inc. is on 20 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details


Insider Trading disclosures for Maze Therapeutics Inc.

The latest disclosure was made by Charles J. Homcy in Maze Therapeutics Inc. where a trade of 28,423 Common Stock done was reported to US exchanges on Oct. 23, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Charles J. Homcy Director Gift of securities by or to the insider at price $ 0.00 per share. 23 Oct 2025 28,423 29,624 - 0 Common Stock
Herve Hoppenot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2025 36,000 36,000 - - Stock Option (Right to Buy)
Neil Exter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 18,000 18,000 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 18,000 18,000 - - Stock Option (Right to Buy)
Daniel K. Spiegelman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 18,000 18,000 - - Stock Option (Right to Buy)
Jonathan E. Lim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 18,000 18,000 - - Stock Option (Right to Buy)
Richard H. Scheller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 18,000 18,000 - - Stock Option (Right to Buy)
Catherine Angell Sohn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 18,000 18,000 - - Stock Option (Right to Buy)
Nancy C. Andrews Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 18,000 18,000 - - Stock Option (Right to Buy)
Jason V. Coloma Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 100,000 100,000 - - Restricted Stock Units
Courtney J. Phillips GC and Corp. Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 22,000 22,000 - - Restricted Stock Units
Sekar Kathiresan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 18,000 18,000 - - Stock Option (Right to Buy)
Harold S. Bernstein President, R&D & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 40,000 40,000 - - Restricted Stock Units
Atul Dandekar CSBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 25,000 25,000 - - Restricted Stock Units
Amy Bachrodt SVP, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 22,000 22,000 - - Restricted Stock Units
Richard H. Scheller Director Sale of securities on an exchange or to another person at price $ 22.37 per share. 15 Sep 2025 20,744 0 - 22.4 464,035 Common Stock
Misbah Tahir Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2025 325,000 325,000 - - Stock Option (Right to Buy)
Neil Exter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2025 16,000 16,000 - - Stock Option (Right to Buy)
Jonathan E. Lim Director 03 Feb 2025 363,703 0 - - Series A Preferred Stock
Jonathan E. Lim Director 03 Feb 2025 37,724 37,724 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 169,405 0 - - Series C Preferred Stock
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 45,638 45,638 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 46,675 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 46,675 46,675 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 5,704 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 5,704 5,704 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 80,385 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 80,385 80,385 - - Stock Option (Right to Buy)
Charles J. Homcy Director 03 Feb 2025 71,564 7,422 - - Series D-1 Preferred Stock
Charles J. Homcy Director 03 Feb 2025 71,564 0 - - Series D-1 Preferred Stock
Charles J. Homcy Director 03 Feb 2025 8,807 37,330 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 72,727 0 - - Series B Preferred Stock
Charles J. Homcy Director 03 Feb 2025 7,422 7,422 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 20,717 58,047 - - Common Stock
Jonathan E. Lim Director 03 Feb 2025 270,232 307,956 - - Common Stock
Jonathan E. Lim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 9,086 9,086 - - Stock Option (Right to Buy)
Jonathan E. Lim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 5,704 0 - - Stock Option (Right to Buy)
Jonathan E. Lim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 5,704 5,704 - - Stock Option (Right to Buy)
Jonathan E. Lim Director 03 Feb 2025 2,231,381 0 - - Series B Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters